ArticlePloS one2026
Co-design of Lifestyle6, a digital tool targeting multiple health behaviour changes for cancer risk reduction and early detection support.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Up to 40% of all cancers diagnosed could be prevented through the uptake of healthy lifestyle behaviours. This paper describes the co-design of a novel community-centric digital programme for cancer prevention and early detection support. Twenty-two community panel members partook in a series (i.e., three group-based sessions followed by one individual session) of iterative online workshops to co-design the programme. Based on established Design Thinking principles, the workshops aimed to i) identify barriers to access and use of existing cancer prevention information and support, ii) explore consumers' needs and preferences for information and support related to cancer risk reduction and early detection, iii) generate ideas for a digital solution to address those, and iv) seek panel members' feedback on a digital prototype developed in line with the insights from previous stages. The key barriers to accessing cancer prevention and screening support identified by the panel included limited availability and knowledge of cancer-specific resources alongside a paradoxical information overload regarding generic options. Panel members expressed concerns about information accuracy and relevance, while time constraints, financial limitations, and motivation deficits further impeded resource engagement. Regarding prototype preferences, participants prioritised accessibility, diversity, communication and connectedness, usability, and personal relevance as essential design elements. Digital solutions for cancer prevention and screening support should offer a customised experience, while catering for varying practical constraints and motivational challenges.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.